Recent 8-K filings for BLCO

• April 29, 2026, 7:59 PM ET earnings materiality 0.80 positive item 2.02item 9.01 ◈ Earnings Releases

  Bausch + Lomb Q1 2026 revenue $1.244B (+9% YoY), raises full-year guidance

  Revenue $1.244B, up 9% reported and 6% constant currency YoY; GAAP net loss narrowed to $71M from $212M.

• February 18, 2026, 6:59 PM ET earnings materiality 0.75 neutral item 2.02item 9.01

  Bausch + Lomb Q4 rev $1.405B (+10%), net loss $58M; guides FY2026 rev $5.375B-$5.475B

  Q4 revenue $1.405B (+10% reported, +7% constant currency); FY revenue $5.101B (+6% reported, +5% constant currency).

• January 2, 2026, 6:59 PM ET debt materiality 0.65 positive item 1.01item 2.03item 8.01item 9.01 ◈ Material Agreements

  Bausch + Lomb completes $2.8B term loan refinancing; margin cut up to 0.50%

  Entered Fourth Amendment providing $2,802,125,000 Replacement Term Loans maturing January 15, 2031.

• November 13, 2025, 6:59 PM ET other material materiality 0.70 positive item 7.01item 9.01

  Bausch + Lomb targets 5-7% revenue CAGR, ~23% EBITDA margin; pipeline peak sales ~$7B

  Targets 5-7% constant currency revenue CAGR 2025-2028.

• October 29, 2025, 7:59 PM ET earnings materiality 0.75 neutral item 2.02item 9.01

  Bausch + Lomb Q3 revenue $1.28B (+7% YoY); narrows FY adjusted EBITDA guidance to $870M-$910M

  Revenue $1.281B, up 7% reported (6% constant currency); Vision Care +8%, Surgical +4%, Pharmaceuticals +8%.

• July 30, 2025, 7:59 PM ET earnings materiality 0.75 positive item 2.02item 9.01

  Bausch + Lomb Q2 revenue $1.278B, GAAP loss narrows to $62M, raises FY2025 guide

  Revenue $1.278B, +5% as reported (+3% constant currency); Vision Care +8%, Surgical +3%, Pharma flat.

• June 27, 2025, 7:59 PM ET debt materiality 0.60 positive item 1.01item 2.03item 8.01item 9.01

  Bausch + Lomb closes €675M notes offering and $2.325B term loan refinancing, extends maturities to 2031

  €675M senior secured floating rate notes due Jan 15, 2031, at EURIBOR + 3.875%, priced at 99.5%.

• June 18, 2025, 7:59 PM ET debt materiality 0.60 neutral item 8.01item 9.01

  Bausch + Lomb prices €675M senior secured notes, upsizes term loan to $2.325B

  Issuers priced €675M senior secured floating rate notes due 2031 at 99.500% of principal, upsized from €600M.

• June 10, 2025, 7:59 PM ET debt materiality 0.60 neutral item 8.01item 9.01

  Bausch + Lomb launches €600M notes offering and $2.2B term loan refinancing

  Subsidiaries launch €600M senior secured floating rate notes offering.

• May 21, 2025, 7:59 PM ET other material materiality 0.60 neutral item 8.01item 9.01

  B+L reports majority shareholder BHC enters standstill pacts with Icahn, Paulson, Kavanagh

  Icahn, Paulson, and Kavanagh groups agree to resign from BHC/B+L boards if they engage in Specified Actions like proxy contests or buying >19.99% of BHC.

• April 30, 2025, 7:59 PM ET earnings materiality 0.80 negative item 2.02item 9.01

  Bausch + Lomb Q1 net loss $212M; enVista recall cuts FY adj. EBITDA guidance by ~$65M

  Revenue $1.137B (+3% reported, +5% constant currency) vs $1.099B YoY.

• February 19, 2025, 6:59 PM ET earnings materiality 0.70 neutral item 2.02item 9.01

  Bausch + Lomb Q4 revenue up 11% CC; FY GAAP loss widens; guides 2025 revenue ~$5B

  Q4 revenue $1.28B, up 9% reported and 11% constant currency, with growth across all segments.

• October 30, 2024, 7:59 PM ET earnings materiality 0.75 positive item 2.02item 9.01

  Bausch + Lomb Q3 revenue $1.196B (+19% YoY); raises FY2024 revenue guidance

  GAAP net income $4M vs net loss of $84M YoY; adjusted EPS $0.13 ($0.17 ex-IPR&D).

• July 31, 2024, 7:59 PM ET earnings materiality 0.80 negative item 2.02item 9.01

  Bausch + Lomb Q2 revenue $1.216B (+17% YoY); GAAP net loss $151M; raises FY2024 guidance

  Revenue $1.216B, up 17% reported and 20% constant currency vs Q2 2023.

• May 1, 2024, 7:59 PM ET earnings materiality 0.75 positive item 2.02item 9.01 ◈ Earnings Releases

  Bausch + Lomb Q1 revenue $1.099B (+18% YoY); raises FY constant-currency growth guidance

  GAAP net loss attributable widened to $167M from $90M; adjusted EBITDA rose to $180M from $141M.

Earnings & guidance

Materiality & sentiment trend

Max materiality 0.80 · Median 0.60 · Most common event earnings

8 positive 2 negative 14 neutral

source · BLCO on sec.gov